Fisher Asset Management’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AMPH
Fisher Asset Management's AMPH Position: Q4 2023 in Review
Fisher Asset Management sold out of Amphastar Pharmaceuticals (AMPH) in Q4 2023, closing a stake of 58 shares — an estimated $2.67K sold.
Fisher Asset Management first reported a position in AMPH in Q3 2015 and held it in 13 quarters. The position peaked at $4.41M in Q4 2017. 277 funds tracked by Wall St. Rank hold AMPH as of Q4 2023.
- Fisher Asset Management reported no remaining Amphastar Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
- Fisher Asset Management sold 58 Amphastar Pharmaceuticals shares in Q4 2023, an estimated $2.67K.
- Fisher Asset Management first reported a position in Amphastar Pharmaceuticals in Q3 2015 and held it in 13 quarters.
- Fisher Asset Management's Amphastar Pharmaceuticals position peaked at $4.41M in Q4 2017.
- 277 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2023.
Based on Fisher Asset Management's 13F filing for Q4 2023, filed 6 Feb 2024.